Immunome logo
Immunome IMNM
$ 23.87 6.49%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Immunome Total Current Liabilities 2011-2026 | IMNM

Annual Total Current Liabilities Immunome

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
21.8 M 7.33 M 9.73 M 3.04 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
21.8 M 3.04 M 10.5 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Adagene Adagene
ADAG
38.2 M $ 1.9 -3.11 % $ 107 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 25.87 -0.79 % $ 1.25 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.71 1.88 % $ 17 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 64.74 1.41 % $ 8.66 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 3.96 -1.0 % $ 8.62 B israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.21 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
3.77 M - -9.72 % $ 5.89 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Biogen Biogen
BIIB
5.53 B $ 164.87 0.27 % $ 24 B usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
1.91 M - - $ 100 K usaUSA
BioVie BioVie
BIVI
2.27 M $ 1.23 2.07 % $ 1.82 M usaUSA
Baudax Bio Baudax Bio
BXRX
21.5 M - 0.59 % $ 63 K usaUSA
Calithera Biosciences Calithera Biosciences
CALA
14 M - -10.95 % $ 876 K usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
25.6 M - -3.03 % $ 260 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA